Inflammatory mechanisms in chronic sinusitis

Acta Oto-Rhino-Laryngologica Belgica

Volumn 51, Issue 4, 1997, Pages 209-217

  Bachert, Cl ^a   Van Cauwenberge, P B ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Chemokines; Cytokines; Inflammation; Interleukin 5; Nasal polyposis; Sinusitis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE DISEASE; CHRONIC DISEASE; CLASSIFICATION; EOSINOPHIL; EOSINOPHILIA; HUMAN; IMMUNOLOGY; MAXILLARY SINUS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NOSE POLYP; PARANASAL SINUS TUMOR; POLYP; REVIEW; RHINITIS; SINUSITIS; VIROLOGY;

ACUTE DISEASE; CELL ADHESION MOLECULES; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CHRONIC DISEASE; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-3; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; MAXILLARY SINUS; NASAL POLYPS; NEUTROPHILS; PARANASAL SINUS NEOPLASMS; POLYPS; RHINITIS; SINUSITIS;

EID: 0031299333     PISSN: 00016497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. LUND V. J., KENNEDY D. W. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol., 104: Suppl. 167, 17-21, 1995.
2. GWALTNEY J. M. Microbiology of sinusitis. In : Druce HM (ed) : Sinusitis : Pathophysiology and treatment. Marcel Dekker, New York 1994: 41-56.
3. BARANIUK J. N. Physiology of sinusitis. In : DRUCE H. M. (ed) : Sinusitis : Pathophysiology and treatment. Marcel Dekker, New York 1994: 19-39.
4. STAMMBERGER H. Endoscopic endonasal surgery -concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiological considerations. Oto-laryngol Head Neck Surg., 94: 143-147, 1986.
5. SETTIPANE G. A., CHAFFEE F. H. Nasal polyps. Am J Rhinol., 1: 119-126, 1987
6. MYGIND N. Nasal polyposis. J Allergy Clin Immunol., 86: 827-829, 1990
7. Tos M., SASAKI Y., OHNISHI M., LARSEN P., DRAKE L. A. Pathogenesis of nasal polyps. Rhinol., Suppl 14: 181-185, 1992.
8. Röseler S., Holtappels G., Wagenmann M., Bachert C. Elevated levels of IL-1β, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolarygol., 252: S61-63, 1995.
9. Gosset P, Malaquin F, Delneste Y, Wallaert B, Capron A, Joseph M, Tonnel AB. Interleukin-6 and interleukin-1a production is associated with antigen-induced late nasal response. J Allergy Clin Immunol., 92: 878-890, 1993.
10. SIM T. C., GRANT J. A., HUSMEIER K. A., FUKUDA Y, ALAM R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med., 149: 339-344, 1994.
11. BACHERT C., HAUSER U., PREM B., RUDACK C., GANZER U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngology, 252: S44-S49, 1995.
12. STIERNA P., CARLSOO B. Histopathological observations in chronic maxillary sinusitis. Acta Otolaryngol. (Stockh) 110: 450-458, 1990.
13. MIN Y. G., CHUNG J. W., SHIN J. S., Cin J. G. Histologic structure of antrochoanal polyps. Acta Otolaryngol. (Stockh), 115: 543-547, 1995.
14. TOKUSHIGE E., ITOH K., USHIKAI M., KATAHIRA S., FUKUDA K. Localization of IL-1β mRNA and cell adhesion molecules in the maxillary sinus mucosa of patients with chronic sinusitis. Laryngoscope 104: 1245-1250, 1994.
15. LUND V. J., HENDERSON B., SONG Y. Involvement of cytokines and vascular adhesion molecules in the pathophysiology of fronto-ethmoidal mucoceles. Acta Otolaryngol. (Stockholm), 113: 540-546, 1993.
16. TAKELICHI K., YUTA A., SAKAKURA Y. Interieukin-8 expression in chronic sinusitis. Am J Otolaryngol., 16: 98-102, 1995.
17. SUZUKI H., TAKAHASHI Y., WATAYA H., IKEDA K., NAKABAYASHI S., SHIMOMURA A., TAKASAKA T. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol., 98: 659-670, 1996.
18. HAMILOS D. L., LEUNG D. Y., WOOD R., MEYERS A., STEPHENS J. K., BARKANS J., MENG Q., CUNNINGHAM L., BEAN D. K., KAY A. B., et al. Chronic hyperplastic sinusitis : association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol., 92: 39-48, 1993.
19. COSTA J. J., MATOSSIAN K., RESNICK M. B., BEIL W. J., WONG D. T., GORDON J. R., DVORAK A. M., WELLER P. F., GALLI S. J. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory' protein-1 alpha. J Clin Invest., 91: 2673-2684, 1993.
20. OHNO I., LEA R. G., FLANDERS K. C., CLARK D. A., BANWATT D., DOLOVICH J., DENBURG J., HARLEY C. B., GAULDIE J., JORDANA M. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest., 89: 1662-1668, 1992.
21. FINOTTO S., OHNO I., MARSHALL J. S., GAULDIE J., DENBURG J. A., DOLOVICH J., CLARK D. A., JORDANA M. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol., 153: 2278-2289, 1994.
22. ELOVIC A., WONG D. T., WELLER P. F., MATOSSIAN K., GALLI S. J. Expression of transforming growth factors-alpha and beta I messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol., 93: 864-869, 1994.
23. BACHERT C., HAUSER U., WAGENMANN M., BRANDT A., DATER I., Prem B. Interleukin-5 protein is detected in nasal polyps (abstract). J Allergy Clin Immunol., 95: 389, 1995.
24. BAROODY F. M., LEE B. J., LIM M. C., BOCHNER B. S. Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngology 252: S50-58, 1995.
25. SCHRADER J. W. Interleukin-3. In : THOMSON A. (ed) : The cytokine handbook. Academic press London, 1994: 81-98.
26. PERSSON C. G. A., ERJEFALT J. S., ANDERSSON M., ERJEFÀLT L., GREIFF L., KURSGREN M., LINDEN M., SUNDLER F., SVENSSON C. Epithelium, microcirculation and eosinophils - new aspects of the allergic airway in vivo. Allergy 52: 241-255, 1997.
27. MYGIND N., DAHI R., LARSEN L., LILDHOLDT T., BACHERT C. Nasal polyposis. In : SZCEKLIK A., GRYGLEWSKI R., VANE J. R. (eds) : Eicosanoids, aspirin and asthma. New York, Marcel Dekker 1997 (in press).
28. BOUSQUET J., CHANEZ P., LACOSTE J. Y., BARNEON G., GAVANIAN N., ENANDER I., VENGE P., AHLSTEDT S., SIMONY-LAKONTAINE J., GODARD P. Eosinophilic inflammation in asthma. N Engl J Med., 323: 1033-1039, 1990.
29. JAHNSEN F. L., HARALDSEN G., AANESEN J. P., HAYE R., BRANDTZAEG P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol., 12: 624-632, 1995.
30. SYMON F. A., WALSH G. M., WATSON S. R., WARDLAW A. J. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med., 180: 371-376, 1994.
31. ALAM R., STAFFORD S., FORSYTHE P., HARRISON R., FAUBION D., LETT BROWN M. A. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol., 150: 3442-3448, 1993.
32. EBTSAWA M, LIU M. C., YAMADA T., KATO M., LICHTENSTEIN L. M., BOCHNER B. S., SCHLEIMER R. P. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J Immunol., 152(9): 4590-4596, 1994.
33. EBISAWA M., YAMADA T., BICKEL C., KLUNK D., SCHLEIMER R. P. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. Immunol., 153(5): 2153-2160, 1994.
34. MARFAING-KOKA A., DEVERGENE O., GORGONE G., PORTIER A., SCHALL, T. J., GALANAUD P., EMILIE D. Regulation of the production of the RANTES chemokine by endothelial cells : synergistic induction by IFN-gamma plus TNF-a and inhibition by IL-4 and IL-13. J Immunol., 154: 1870-1878, 1995.
35. BECK L. A., SCHALL T. J., BEALL L. D., LEOPOLD D., BICKEL C., BAROODY F. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps. J Allergy Clin Immunol., 93: 234 (abstr.), 1994.
36. MAUNE S., MEYER J. E., STICHERLING M., FÖLSTER-HOLST P., SCHRÖDER J. M. Eosinophilen-chemotaktische Aktivität in der Chemokinfraktion von Nasenpolypen. Allergologie, 19: 230-233, 1996.
37. GARCIA-ZEPEDA E. A., ROTHENBERG M. E., OWNBEY R.T., CELESTIN J., LEDER P., LUSTER A. D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med., 2: 449-456, 1996.
38. COLLINS P. D., MARLEAU S., GRIFFITHS-JOHNSON D. A., JOSE P. J., WILLIAMS T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med., 182: 1169-1174, 1995.
39. KITAURA M., NAKAJAMA T., IMAI T., HARADA S., COMBADIERE C., TIFFANY H. L., MURPHY P.M., YOSHIE O. Molecular cloning of human eotaxin, an eosinophil-specific CC chemokine, and identification of a specific receptor, CC chemokine receptor 3. J. Biol. Chem., 271: 7725-7730, 1996.
40. ELSNER J., HOCHSTETTER R., KIMMIG D., KAPP A. Human eotaxin represents a potent activator of the respiratory burst in human eosinphils. Eur J Immunol., 26: 1919-1925, 1996.
41. PONATH P. D., QIN S., RINGLER D. J., CLARK-LEWIS I., WANG J., KASSAM N., SMITH H., SHI X., GONZALO J. A., NEWMAN W., GUTIERREZ-RAMOS J. C., MACKAY C. R. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest, 97: 604-612, 1996.
42. HAMILOS D. L., LEUNG D. J., WOOD R., CUNNINGHAM L., BEAN D. K., YASRUEL Z., SCHOTMAN E., HAMID Q. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol., 96: 537-544, 1995.
43. BACHERT C., WAGENMANN M., HAUSER U., RUDACK C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 99 : (in press), 1997.
44. SIMON H. U., BLASER K. Inhibition of programmed eosinophil death : a key pathogenic event for eosinophilia ? Immunol Today 16: 53-55, 1995.
45. SIMON H. U., YOUSEFI S., SCHRANZ C., SCHAPOWAL A., Bachert C., Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol., 158: 3902-3908, 1997.